264 related articles for article (PubMed ID: 15644400)
1. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.
Grey A; Lucas J; Horne A; Gamble G; Davidson JS; Reid IR
J Clin Endocrinol Metab; 2005 Apr; 90(4):2122-6. PubMed ID: 15644400
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
[TBL] [Abstract][Full Text] [Related]
3. Urinary calcium excretion in primary hyperparathyroidism: relationship to 25-hydroxyvitamin d status.
Bussey AD; Bruder JM
Endocr Pract; 2005; 11(1):37-42. PubMed ID: 16033734
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial.
Rolighed L; Rejnmark L; Sikjaer T; Heickendorff L; Vestergaard P; Mosekilde L; Christiansen P
J Clin Endocrinol Metab; 2014 Mar; 99(3):1072-80. PubMed ID: 24423366
[TBL] [Abstract][Full Text] [Related]
5. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature.
Shah VN; Shah CS; Bhadada SK; Rao DS
Clin Endocrinol (Oxf); 2014 Jun; 80(6):797-803. PubMed ID: 24382124
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D treatment in primary hyperparathyroidism.
Rolighed L; Bollerslev J; Mosekilde L
Curr Drug Saf; 2011 Apr; 6(2):100-7. PubMed ID: 21524245
[TBL] [Abstract][Full Text] [Related]
7. Low vitamin D levels have become less common in primary hyperparathyroidism.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
[TBL] [Abstract][Full Text] [Related]
9. Management of hypovitaminosis D in patients with primary hyperparathyroidism.
Rathi MS; Gonzalez S; Wright D; Ellis NR; Peacey SR
J Endocrinol Invest; 2014 May; 37(5):467-71. PubMed ID: 24515299
[TBL] [Abstract][Full Text] [Related]
10. Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency.
Isidro ML; Ruano B
Endocrine; 2009 Oct; 36(2):305-10. PubMed ID: 19598008
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D.
Tucci JR
Eur J Endocrinol; 2009 Jul; 161(1):189-93. PubMed ID: 19383807
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
13. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D.
Vieth R; Ladak Y; Walfish PG
J Clin Endocrinol Metab; 2003 Jan; 88(1):185-91. PubMed ID: 12519850
[TBL] [Abstract][Full Text] [Related]
14. Impact of vitamin D replacement in patients with normocalcaemic and hypercalcaemic primary hyperparathyroidism and coexisting vitamin D deficiency.
Das G; Eligar V; Govindan J; Bondugulapati LN; Okosieme O; Davies S
Ann Clin Biochem; 2015 Jul; 52(Pt 4):462-9. PubMed ID: 25468998
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism.
Kantorovich V; Gacad MA; Seeger LL; Adams JS
J Clin Endocrinol Metab; 2000 Oct; 85(10):3541-3. PubMed ID: 11061498
[TBL] [Abstract][Full Text] [Related]
16. Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism.
Ozbey N; Erbil Y; Ademoğlu E; Ozarmağan S; Barbaros U; Bozbora A
World J Surg; 2006 Mar; 30(3):321-6. PubMed ID: 16467981
[TBL] [Abstract][Full Text] [Related]
17. Serum 25-Hydroxyvitamin D Insufficiency in Search of a Bone Disease.
Shah S; Chiang C; Sikaris K; Lu Z; Bui M; Zebaze R; Seeman E
J Clin Endocrinol Metab; 2017 Jul; 102(7):2321-2328. PubMed ID: 28379394
[TBL] [Abstract][Full Text] [Related]
18. The impact of vitamin D status and parameters of calcium metabolism in patients with primary hyperparathyroidism.
Tripto-Shkolnik L; Jaffe A; Liel Y
QJM; 2018 Feb; 111(2):97-101. PubMed ID: 29462468
[TBL] [Abstract][Full Text] [Related]
19. Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
Strugnell SA; Sprague SM; Ashfaq A; Petkovich M; Bishop CW
Am J Nephrol; 2019; 49(4):284-293. PubMed ID: 30878999
[TBL] [Abstract][Full Text] [Related]
20. The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region.
Raef H; Ingemansson S; Sobhi S; Sultan A; Ahmed M; Chaudhry M
J Endocrinol Invest; 2004 Oct; 27(9):807-12. PubMed ID: 15648543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
